Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

Hedy Lee Kindler, Silvia Novello, Alessandra Bearz et al. · The Lancet Oncology · 2022

Cited by 68 works. doi:10.1016/s1470-2045(22)00061-4

Authors

References